International Conference on Neurogenetics and Molecular Neurobiology Advances (ICNMNA - 26)

This track will explore the genetic underpinnings of various brain disorders, focusing on how specific genetic variations contribute to disease susceptibility. Researchers will present findings on the interplay between genetic factors and environmental influences in the manifestation of neurological conditions.

This session will delve into the molecular mechanisms that govern neurodevelopment, highlighting key genes and signaling pathways involved in neuronal differentiation and maturation. Presentations will cover both normal developmental processes and the disruptions that lead to neurodevelopmental disorders.

Focusing on the molecular aspects of synaptic regulation, this track will discuss how genetic factors influence synaptic plasticity and connectivity. Researchers will share insights into the role of synaptic proteins and their implications for learning, memory, and neuropsychiatric disorders.

This session will address the identification and characterization of genetic risk factors associated with various neurological diseases. Presentations will highlight advances in genomic technologies and their application in understanding the heritability of these conditions.

This track will focus on the molecular mechanisms underlying neurodegenerative diseases, such as Alzheimer's and Parkinson's. Researchers will present data on the role of genetic mutations, protein aggregation, and cellular stress responses in neurodegeneration.

This session will explore the complex signaling pathways that regulate neuronal function and communication. Emphasis will be placed on the genetic regulation of these pathways and their implications for neuronal health and disease.

This track will cover cutting-edge genomic techniques used to study the nervous system, including CRISPR, RNA-seq, and single-cell genomics. Participants will discuss how these technologies are advancing our understanding of neural function and pathology.

This session will highlight recent advances in molecular neuroscience, focusing on the challenges faced in translating basic research findings into therapeutic strategies. Discussions will include innovative approaches to drug development and gene therapy for neurological disorders.

This track will investigate the relationship between genetic variations in the brain and behavioral phenotypes. Researchers will present studies linking genomic data to cognitive functions, emotional regulation, and psychiatric conditions.

Focusing on synaptic disorders such as autism and schizophrenia, this session will discuss the neurobiological mechanisms that underlie these conditions. Presentations will explore genetic contributions and potential therapeutic targets for intervention.

This track will emphasize the importance of translating neurogenetic research into clinical practice. Discussions will center on the integration of genetic findings into diagnostic and therapeutic frameworks for neurological diseases.